Page last updated: 2024-09-03

sb 211475 and allopurinol

sb 211475 has been researched along with allopurinol in 1 studies

Compound Research Comparison

Studies
(sb 211475)
Trials
(sb 211475)
Recent Studies (post-2010)
(sb 211475)
Studies
(allopurinol)
Trials
(allopurinol)
Recent Studies (post-2010) (allopurinol)
60115,0967433,363

Protein Interaction Comparison

ProteinTaxonomysb 211475 (IC50)allopurinol (IC50)
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase Rattus norvegicus (Norway rat)3.3765
Xanthine dehydrogenase/oxidaseHomo sapiens (human)3.1861
Xanthine dehydrogenase/oxidaseBos taurus (cattle)5.0758
Histamine H3 receptorCavia porcellus (domestic guinea pig)8.69

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feuerstein, GZ; Gu, JL; Lysko, KA; Lysko, PG; Mckenna, PJ; Ruffolo, RR; Yue, TL1

Other Studies

1 other study(ies) available for sb 211475 and allopurinol

ArticleYear
SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.
    European journal of pharmacology, 1994, Jan-14, Volume: 251, Issue:2-3

    Topics: Adenosine Diphosphate; Animals; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Brain; Carbazoles; Cattle; Cell Death; Cells, Cultured; Chromans; Endothelium, Vascular; Fumarates; Humans; Iron; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Mice; Neurons; Neutrophils; Nicardipine; Oxidation-Reduction; Piperazines; Propanolamines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxides; Tetradecanoylphorbol Acetate; Xanthine; Xanthine Oxidase; Xanthines

1994